Cart
sales@molnova.com
Glufosfamide
CAS No. 132682-98-5
Glufosfamide ( D-19575;D19575 )
Catalog No. M11306 CAS No. 132682-98-5
A conjugate of glucose and active alkylating moiety of ifosfamide with potentially enhanced selectivity for tumors that overexpress transmembrane glucose transporters.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 239 | Get Quote |
|
| 50MG | 1251 | Get Quote |
|
| 100MG | 1971 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGlufosfamide
-
NoteResearch use only, not for human use.
-
Brief DescriptionA conjugate of glucose and active alkylating moiety of ifosfamide with potentially enhanced selectivity for tumors that overexpress transmembrane glucose transporters.
-
DescriptionA conjugate of glucose and active alkylating moiety of ifosfamide with potentially enhanced selectivity for tumors that overexpress transmembrane glucose transporters; has the better cell permeability than ifosfamide; Glufosfamide utilizes the normal cell glucose transport mechanism (SAAT1) for transport into the cell, enhances the activity of gemcitabine in vitro and in vivo.Pancreatic Cancer Phase 3 Clinical
-
SynonymsD-19575;D19575
-
PathwayCell Cycle/DNA Damage
-
TargetDNA Alkylator
-
RecptorDNA Alkylator
-
Research AreaCancer
-
IndicationPancreatic Cancer
Chemical Information
-
CAS Number132682-98-5
-
Formula Weight383.16
-
Molecular FormulaC10H21Cl2N2O7P
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=P(NCCCl)(NCCCl)O[C@H]1[C@@H]([C@H]([C@@H]([C@@H](CO)O1)O)O)O
-
Chemical NameN,N'-Bis(2-chloroethyl)phosphorodiamidic acid beta-D-glucopyranosyl ester
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Veyhl M, et al. Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):2914-9.
2. Styczynski J, et al. Anticancer Res. 2002 Jan-Feb;22(1A):247-50.
3. Seker H, et al. Br J Cancer. 2000 Feb;82(3):629-34.
4. Ammons WS, et al. Neoplasia. 2007 Aug;9(8):625-33.
2. Styczynski J, et al. Anticancer Res. 2002 Jan-Feb;22(1A):247-50.
3. Seker H, et al. Br J Cancer. 2000 Feb;82(3):629-34.
4. Ammons WS, et al. Neoplasia. 2007 Aug;9(8):625-33.
molnova catalog
related products
-
Carboplatin
A chemotherapy agent that interferes with DNA replication and kills cancer cells; induces growth arrest and/or apoptosis in most cancer cell types; an alkylating agent for treatment of a number of cancers.
-
OBI-3424
OBI-3424 (AST-3424, TH-3424) is a first-in-class, novel prodrug that selectively targets cancers overexpressing the enzyme AKR1C3, OBI-3424 is a highly selective prodrug that is converted by AKR1C3 to a DNA alkylating agent.
-
Thio-TEPA
An alkylating agent used to treat cancer that has been previously used in the palliation of a wide variety of neoplastic diseases.
